Minireviews
Copyright ©The Author(s) 2021.
World J Biol Chem. Nov 27, 2021; 12(6): 104-113
Published online Nov 27, 2021. doi: 10.4331/wjbc.v12.i6.104
Figure 2
Figure 2 Implication of decreased dipeptidyl-peptidase-4 activity, increased Glucagon-like peptide-1, increased Glucagon-like peptide-1-receptor agonists, and decreased mammalian/mechanistic target of rapamycin activity for the neuroprotection. Arrowhead means stimulation whereas hammerhead represents inhibition. Note that some critical pathways have been omitted for clarity. GLP1: Glucagon-like peptide-1; mTOR: Mammalian/mechanistic target of rapamycin; DPP4: Dipeptidyl-peptidase-4.